Introduction
VAT and SAT are distinct adipose depots that can be quantified using advanced radiographic techniques such as computed tomography (CT) and magnetic resonance imaging (MRI). While not routinely measured clinically, both VAT and SAT have been correlated with metabolic risk factors. In particular, VAT is associated with insulin resistance and markers of oxidative stress and inflammation. [1] [2] [3] [4] Obesity is known to be a heterogeneous condition, and metabolic risk can vary widely among obese individuals. 5 A better understanding of the risks associated with distinct adipose depots may help explain some of this heterogeneity.
While both VAT and SAT are associated with an adverse metabolic risk profile, less is known about whether VAT or SAT predict future development of cardiovascular risk factors.
Prior work has suggested that VAT, but not SAT or total fat mass predicted incident diabetes. 6 VAT has been reported to predict development of cardiovascular disease or risk factors among certain ethnicities or specific age groups. [7] [8] [9] Moreover, whether fat quality in different depots contributes to incident metabolic risk factors has not been widely explored. Large prospective studies evaluating both the volume and quality of distinct fat depots and their associations with development of metabolic risk factors are lacking. Thus, we sought to evaluate whether VAT or SAT volume and attenuation (as an indirect measure of fat quality) predicts development of a broad array of traditional cardiovascular risk factors over and above what is accounted for by BMI in a large population-based study.
Methods

Study Participants
The Framingham Heart Study is a longitudinal study of cardiovascular risk factors that began in known about whether VAT or SAT predict future development of cardiovascular r r ri ri risk sk sk f f fac ac acto to tors rs rs.
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VAT and SAT Measurements
Participants underwent MDCT of the chest and abdomen using Discovery VCT 64-slice PET/CT scanner (GE Healthcare). Thirty contiguous 5-mm thick slices (120kVP; 100-300mA dependent on BMI) were acquired, beginning 2 cm above the S1 vertebra. Subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) volumes were measured using the Aquarius 3D
Workstation (TeraRecon Inc., San Mateo, CA). SAT and VAT attenuation in Hounsfield units (HU) were measured using a previously described protocol. 12 Briefly, the abdominal muscular wall separating the visceral and subcutaneous compartments was traced manually, and fat tissue was identified by HU attenuation between -195 and -45. Average HU of each fat depot generated the fat attenuation measure. In a previous study, our group reported high inter-reader and intra-reader correlation (0.997 for SAT, 0.992 for VAT).
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Metabolic Risk Factor Assessment
Metabolic risk factors were assessed at baseline and follow-up examinations. Seated systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured as part of the physician
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Covariate Assessment
Covariates were measured at the baseline exam. Height, weight and waist circumference at the level of the umbilicus were measured on site as part of each examination cycle. BMI was calculated as the weight in kilograms divided by the square of the height in meters. A technician-administered physical activity questionnaire yielded a physical activity index based on average number of hours of daily sleep and level of reported activity (sedentary, slight, moderate or high). Alcohol intake was assessed at the physician interview; moderate to heavy alcohol intake was defined as > 14 drinks/week in men and > 7 drinks/week in women.
Participants were considered current smokers (if they had smoked at least 1 cigarette per day for the previous year), former smokers or never smokers. Women were classified as being menopausal if they had no menstrual bleeding for at least 1 year. Use of hormone replacement was assessed at the physician interview.
Statistical Analysis
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Results
Study Sample Characteristics
Sex-specific baseline characteristics of study participants are shown in Table 1 . Of the 1730 included individuals, nearly half (45%) were women. Mean age at baseline was 46.0 years among women and 44.1 years among men. Mean BMI was in the overweight range for both women and men.
Fat volume and Incident CVD Risk Factors
Results of sex-specific linear and logistic regression models predicting changes in metabolic parameters from VAT and SAT volume are shown in Tables 2 and 3 .
Among women, baseline VAT volume was associated with incident increases in metabolic risk factors. For example, for each additional 500 cm 3 in baseline VAT, we observed a 2.34 mg/dL increase in fasting glucose from baseline to follow up (95% CI 1.71-2.97), and a multiple comparisons.
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For each additional 500 cm 3 in VAT at baseline, the odds of the metabolic syndrome were 2.58 times higher (95% CI 2.05-3.25, p<0.0001). In most cases, significance persisted after BMI adjustment.
In men, increased baseline VAT volume was also associated with higher odds of several incident risk factors. We observed higher odds of hypertension (OR 1.28, 95% CI 1.12-1.47) and metabolic syndrome (OR 1.70, 95% CI 1.45-1.98) (p<0.001 in both cases) for every 500 cm 3 increment in VAT volume, and for these outcomes, the findings persisted after BMI adjustment.
Baseline SAT volume was associated with changes in some risk factors over time among women. Tests for sex interaction were significant for several outcomes, and uniformly the associations between each fat exposure and outcomes were more adverse among women ( Tables   2 and 3 ). For example, a significant sex-interaction was detected for HDL-cholesterol predicted by baseline VAT volume (p = 0.01, Table 2 ), whereby the results were stronger in women (per 500 cm 3 increment in VAT volume, HDL-cholesterol was 1.62 mg/dL lower among women at follow up versus 0.44 mg/dL lower among men at follow up).
Fat Attenuation and Incident Risk Factors
Results of sex-specific linear and logistic regression models for fat attenuation are shown in ba ba base se seli li line ne ne S S SAT AT AT vol ol olum m ume e e we e were re re n n not ot ot a a ass ss ssoc oc ocia ia iate te ted d d wi i with th th s s si i ign gn gnif if ific ic ican an ant t t ch ch chan an ange ge ges s s in in in r r ris is isk k k fa fa fact ct ctor or ors s s ov o over er er t t tim im ime e e. Tables 4 and 5 . Among women, lower fat attenuation was associated with a more adverse metabolic profile at follow-up. For example, for a 5 unit decrease in VAT HU at baseline, we observed a 0.08 mg/dL increase in log triglycerides (95% CI 0.05-0.12, p=0.005) at follow up.
For a 5 unit decrease in SAT HU at baseline, we observed a 2.19 mm Hg increase in SBP (95% 1.35-3.03, p<0.0001). These findings remained significant after adjustment for baseline fat volume. Among men, VAT HU and SAT HU were associated with changes in risk factors including SBP and glucose from baseline to follow up, however these changes were attenuated after adjusting for baseline fat volume. In secondary analyses adjusting the fat attenuation models for either VAT or BMI, the results were generally similar to the fat attenuation models adjusted for the corresponding fat volume only (Supplementary Tables 1 and 2 ).
Several sex interactions were noted in the regression models predicting changes based on fat attenuation (Tables 4 and 5 ). The sex-specific models suggested that the changes in risk factors per decrement in fat attenuation were more pronounced among women. For example, significant sex interactions were detected between fat attenuation (both SAT HU and VAT HU) and HDL-cholesterol (p<0.001 and p<0.05, respectively); in the sex-specific models, HDLcholesterol decreased more among women than among men per 5 HU decrement in fat attenuation.
Figures 1 and 2 depict sex-specific baseline prevalence of selected risk factors stratified
byVAT attenuation tertiles and SAT attenuation tertiles, respectively, within BMI categories (normal, overweight or obese). Figure 1 shows a general pattern of higher baseline prevalence of risk factors among the lowest VAT attenuation tertiles within each BMI category. This pattern is less pronounced for SAT attenuation.
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In the context of the current literature
The present study prospectively examined the association between both fat volume and attenuation and incident metabolic risk factors. Our results expand upon prior work that has shown associations between VAT volume and incident metabolic risk. Published studies have shown a correlation between VAT volume and incidence of type 2 diabetes, 6, 8 hypertension 7 and dyslipidemia. 16 Our findings were observed in both women and men. We robustly assessed and adjusted for a number of possible confounders. The association between VAT and metabolic risk factors persisted after BMI adjustment, further supporting the idea that VAT is a unique pathogenic depot that confers risk beyond its contribution to overall adiposity.
There is less published data about incident associations of SAT volume. A recent study of 732 obese adults divided participants into tertiles of SAT volume and found no trend for incident diabetes with increasing SAT. 6 In the present study, we observed associations between SAT and several incident risk factors, particularly among women. These findings relate in part to our larger sample size, which lends better power to detect differences, and our robust n the context of the current literature
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Fat quality in association with metabolic risk has been less extensively explored than fat volume. We have previously shown that lower VAT and SAT attenuation (i.e. more negative HU) was cross-sectionally associated with a more adverse metabolic profile even after adjustment for absolute fat volume. 12 The results from the present study extend these findings to suggest that measurement of fat quality can predict future development of metabolic risk factors, and that for women, fat quality is predictive of selected incident CVD risk factors beyond fat volume alone.
Potential mechanisms
The unique pathogenic property of VAT, beyond its contributions to overall adiposity, may be due its role as an endocrine organ secreting adipokines that contribute to inflammation and insulin resistance. It is known that macrophages infiltrate VAT, leading to inflammation. 17, 18 It is also known that VAT secretes a more pro-inflammatory cytokine profile than SAT, characterized by higher TNF-alpha and other pro-inflammatory molecules.
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The observation that SAT is associated with metabolic risk factors is partly explained by its contribution to overall adiposity. Our observation that, in women, SAT may have adverse metabolic effects beyond overall adiposity may be partly due to the fact that women have a wider baseline range of SAT volume compared to men (shown in Table 1 ). This wider range at baseline allows for better detection of differences based on SAT volume. 20 Thus any unique pathogenic properties are likely to be more pronounced. For example serum leptin levels are more correlated with SAT than with VAT.
High leptin may indicate leptin resistance, which is predictive of type 2 diabetes. 21 Another possibility is that in women, SAT is less likely to proliferate new cells (hyperplasia) and instead expands primarily by increasing adipocyte size
The unique pathogenic property of VAT, beyond its contributions f to overall adipo o osi si sity ty ty, , , ma ma may y y be be be due its role as an endocrine organ secreting adipokines that contribute to inflammation and nsu uli li lin n n re re resi si sist st stan a a ce e e. It is known that macrophages s s in in infi f f ltrate VAT, leadin n ng g g to t t inflammation. Th Th The e e ob ob obse se serv r rvat at atio io ion n n th th that at at S S SAT AT AT i i is s s as as asso so soci ci ciat at ated ed ed wit it ith h h me me meta ta tabo bo boli li lic c c ri ri risk sk sk f f fac ac acto to tors rs rs i i is s s pa pa part rt rtly l ly e e exp p xpla la lain in ined ed ed b b by (hypertrophy). 22 Increased adipocyte size is associated with insulin resistance. 23, 24 This may represent failure of SAT to expand sufficiently to store excess fat, leading to accumulation into VAT or other ectopic depots. However, a secondary analysis found that the associations of SAT with CVD risk factors in women were not materially different after adjusting for VAT volume.
The observation that both VAT and SAT attenuation, as indirect measures of fat quality, are associated with metabolic risk factors may relate to the fact that more negative fat attenuation represents more lipid-dense fat tissue, which in turn correlates with adipocyte size. 25 As noted above, larger adipocyte size may represent an inability to proliferate new adipocyte cells and is associated with insulin resistance. 24 The observation that the associations of fat quality with metabolic risk are not fully explained by fat volume, again suggests that SAT in women may have limited capacity for hyperplasia, leading to ectopic fat deposition. 26 An alternative hypothesis for the relevance of fat quality in predicting metabolic risk is that fat quality may be affected by vascularity of adipose tissue. Blood has higher HU attenuation than fat on CT. 27 Thus, lower HU attenuation of a fat depot may indicate relative dearth of vascularity. It is plausible that lack of vascularity could lead to hypoxia and higher inflammation, both of which may mediate pathogenic effects of adipose tissue.
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Implications
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Strengths and limitations
The large sample size is a strength of our study. Fat depots were precisely assessed with validated tools and strong inter-reader reliability. The data is prospective and allowed us to assess change over time. Metabolic risk factors were directly measured on site, which is more reliable than self-report. Because this is an observational study, we cannot infer causality between the measures of VAT and SAT and the metabolic outcomes. The Framingham cohort is primarily white, thus results may not be generalizable to other ethnicities. Finally, the numbers of some of the incident clinical risk factors were low. Our continuous analysis reinforces the association between increasing fat quantity and lower attenuation and change in CVD risk factors over time.
Conclusion
Both VAT and SAT volume are associated with incident metabolic risk factors after BMI adjustment, particularly among women. Fat attenuation, as an indirect measure of fat quality, provides additional information beyond fat volume. These findings suggest that both volume and quality of distinct fat depots contribute to an individual's metabolic risk, and that knowledge of the properties of fat depots has the potential to further our understanding of the heterogeneous metabolic risks conferred by obesity.
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